Latest rheumatoid arthritis Stories
BIRMINGHAM, Ala. and BATON ROUGE, La. and RALEIGH, N.C. and RESEARCH TRIANGLE PARK, N.C., Dec.
DALLAS, December 1, 2014 /PRNewswire/ -- ReportsnReports.com adds EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 market research on the autoimmune
DailyGossip.org reviews the Paddison Program, a new remedy for rheumatoid arthritis, which promises to help sufferers achieve a simple natural cure and overcome all symptoms. Denver,
On December 5th, 2014, “Broads for Bones with the Biggest D&*k in Hollywood!” will take place at Three Clubs Cocktail Lounge, 1123 N. Vine St. Hollywood CA 90038.
DALLAS, November 27, 2014 /PRNewswire/ -- ReportsnReports.com adds Rheumatoid Arthritis - Pipeline Review, H2 2014 market research report that provides comprehensive information
U.S. Court of Appeals for the Federal Circuit Concurrently Affirms Denial of Antares Pharma's Motion to Prohibit the Marketing of Rasuvo CHICAGO, Nov.
ReportsnReports.com adds Rheumatoid Arthritis Global Clinical Trials Review H2 2014 to its store.
PETACH TIKVA, Israel, Nov. 18, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
- Secukinumab met primary endpoints demonstrating statistically significant improvements versus placebo in signs and symptoms of active psoriatic arthritis (PsA) in two pivotal Phase III studies
- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.
- Growing in low tufty patches.